Because there has been evidence showing that obesity-related FTO gene variants were associated with pancreatic cancer only in overweight people21, we conducted additional analyses examining a possible effect modification by BMI. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.